<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Regenera Insights Inc. — News on 6ix</title>
<link>https://6ix.com/company/regenera-insights-inc</link>
<description>Latest news and press releases for Regenera Insights Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/regenera-insights-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6b3b3beedb30cb6ffa9dd.webp</url>
<title>Regenera Insights Inc.</title>
<link>https://6ix.com/company/regenera-insights-inc</link>
</image>
<item>
<title>Repligen to Report First Quarter 2026 Financial Results</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-first-quarter-2026-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-first-quarter-2026-financial-results</guid>
<pubDate>Wed, 22 Apr 2026 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today annou...</description>
</item>
<item>
<title>Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-opens-european-training-and-innovation-center-in-breda-expanding-global-customer-support-network-1</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-opens-european-training-and-innovation-center-in-breda-expanding-global-customer-support-network-1</guid>
<pubDate>Fri, 17 Apr 2026 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sci...</description>
</item>
<item>
<title>Repligen Corporation to Present at Upcoming March Conferences</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-march-conferences-10</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-march-conferences-10</guid>
<pubDate>Thu, 05 Mar 2026 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sci...</description>
</item>
<item>
<title>Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-2026-financial-guidance-1</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-2026-financial-guidance-1</guid>
<pubDate>Tue, 24 Feb 2026 12:30:00 GMT</pubDate>
<description>Fourth quarter revenue of $198 million, a year-over-year increase of 18% as reported, 14% organic...</description>
</item>
<item>
<title>Repligen to Report Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Tue, 10 Feb 2026 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announ...</description>
</item>
<item>
<title>Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-executive-chair-tony-hunt-to-retire-dr-martin-d-madaus-elected-chair</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-executive-chair-tony-hunt-to-retire-dr-martin-d-madaus-elected-chair</guid>
<pubDate>Tue, 06 Jan 2026 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-jp-morgan-2026-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-jp-morgan-2026-healthcare-conference</guid>
<pubDate>Thu, 18 Dec 2025 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-introduces-next-generation-chromatography-resins-to-advance-new-modality-workflows</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-introduces-next-generation-chromatography-resins-to-advance-new-modality-workflows</guid>
<pubDate>Tue, 16 Dec 2025 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Corporation to Present at Evercore Healthcare Conference</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-evercore-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-evercore-healthcare-conference</guid>
<pubDate>Wed, 26 Nov 2025 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Corporation to Present at Upcoming November Conferences</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-november-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-november-conferences</guid>
<pubDate>Tue, 04 Nov 2025 12:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-reports-third-quarter-2025-financial-results-and-updates-full-year-2025-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-reports-third-quarter-2025-financial-results-and-updates-full-year-2025-financial-guidance</guid>
<pubDate>Tue, 28 Oct 2025 11:30:00 GMT</pubDate>
<description>Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with ...</description>
</item>
<item>
<title>Repligen to Report Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-third-quarter-2025-financial-results</guid>
<pubDate>Wed, 15 Oct 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announ...</description>
</item>
<item>
<title>Repligen Corporation to Present at Upcoming September Conferences</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-september-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-september-conferences</guid>
<pubDate>Fri, 22 Aug 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-announces-strategic-partnership-with-novasign-to-further-advance-bioprocessing-digitalization</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-announces-strategic-partnership-with-novasign-to-further-advance-bioprocessing-digitalization</guid>
<pubDate>Thu, 31 Jul 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scie...</description>
</item>
<item>
<title>Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-reports-second-quarter-2025-financial-results-and-updates-full-year-2025-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-reports-second-quarter-2025-financial-results-and-updates-full-year-2025-financial-guidance</guid>
<pubDate>Tue, 29 Jul 2025 11:30:00 GMT</pubDate>
<description>Revenue of $182 million, year-over-year increase of 15% as reported and 17% organic non-COVID gro...</description>
</item>
<item>
<title>Repligen to Report Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-second-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-to-report-second-quarter-2025-financial-results</guid>
<pubDate>Thu, 17 Jul 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announ...</description>
</item>
<item>
<title>Repligen Announces Publication of the Company's&#xA0;2024 Corporate Sustainability Report</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-announces-publication-of-the-companysandxa02024-corporate-sustainability-report</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-announces-publication-of-the-companysandxa02024-corporate-sustainability-report</guid>
<pubDate>Tue, 27 May 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scien...</description>
</item>
<item>
<title>Repligen Corporation to Present at William Blair Growth Conference</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-william-blair-growth-conference</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-william-blair-growth-conference</guid>
<pubDate>Thu, 22 May 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scien...</description>
</item>
<item>
<title>Repligen Corporation to Present at Upcoming May Investor Conferences</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-may-investor-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-corporation-to-present-at-upcoming-may-investor-conferences</guid>
<pubDate>Wed, 07 May 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life scien...</description>
</item>
<item>
<title>Repligen Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/regenera-insights-inc/news/repligen-reports-first-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/regenera-insights-inc/news/repligen-reports-first-quarter-2025-financial-results</guid>
<pubDate>Tue, 29 Apr 2025 11:30:00 GMT</pubDate>
<description>Revenue of $169 million, year-over-year increase of 10% as reported and 14% organic non-COVID gro...</description>
</item>
</channel>
</rss>